The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Serum hepatocyte growth factor and interleukin-6 as prognostic markers for stage III non-small cell lung cancer.
Hideki Ujiie
No relevant relationships to disclose
Mikio Tomida
No relevant relationships to disclose
Hirohiko Akiyama
No relevant relationships to disclose
Daisuke Okada
No relevant relationships to disclose
Yuki Nakajima
No relevant relationships to disclose
Hiroshi Sakai
No relevant relationships to disclose
Yuichi Takiguchi
No relevant relationships to disclose
Hideki Tanzawa
No relevant relationships to disclose